Eric Lisle, president and CEO of Southeast Primary Care Partners, discusses the importance of comprehensive patient data for primary care practices implementing value-based care.
Eric Lisle, president and CEO of Southeast Primary Care Partners, shared his insight on the importance of comprehensive patient data in value-based primary care and the challenge physicians face when it is not entirely available.
Transcript
What are some challenges that primary care physicians may face in implementing value-based care?
When you think about what you need in order to manage a person's care, really the most important thing is you need data. You need to know what's going on with that patient. You need to be able to identify conditions associated with that person's care, you need to be able to see what's going on outside of your ecosystem. So for example, in our EMR [electronic medical record], we're not really tied in from an EMR perspective to a lot of other places, so we only have visibility about our patient limited to what's inside our EMR. We have to construct a whole person picture around the patient that says we've done diagnostic testings to identify these conditions, we've looked at claims data that exist in the total health system to identify things that are happening outside of our primary care clinics, to help us see what's needed for the primary care physician to do, and recommend activities for the patients that are going to be beneficial to their health. I'd say the number one thing is to get data from all sources to feed into your primary care physicians' EMR workflow, so that they can manage the patients effectively.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More